My Legacy Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$652K Buy
25,278
+12,951
+105% +$302K 0.23% 117
2025
Q1
$312K Buy
12,327
+424
+4% +$11.1K 0.12% 166
2024
Q4
$312K Buy
11,903
+239
+2% +$6.48K 0.12% 167
2024
Q3
$338K Sell
11,664
-1,562
-12% -$45.6K 0.13% 163
2024
Q2
$370K Sell
13,226
-124
-0.9% -$3.41K 0.12% 175
2024
Q1
$370K Sell
13,350
-596
-4% -$16.5K 0.12% 177
2023
Q4
$396K Buy
13,946
+507
+4% +$15.3K 0.14% 164
2023
Q3
$419K Sell
13,439
-215
-2% -$7.6K 0.17% 156
2023
Q2
$492K Sell
13,654
-37
-0.3% -$1.44K 0.19% 151
2023
Q1
$571K Sell
13,691
-4,938
-27% -$213K 0.24% 136
2022
Q4
$821K Sell
18,629
-123
-0.7% -$5.9K 0.35% 99
2022
Q3
$804K Buy
18,752
+436
+2% +$21.2K 0.41% 77
2022
Q2
$969K Buy
18,316
+348
+2% +$17.7K 0.48% 62
2022
Q1
$930K Buy
+17,968
New +$932K 0.43% 72

Other funds holding PFE

My Legacy Advisors's PFE Position: Q2 2025 in Review

My Legacy Advisors increased its Pfizer (PFE) stake by 105% in Q2 2025, buying an estimated $302K and bringing the position to 25,278 shares worth $652K. The position accounts for 0.23% of the portfolio, ranked #117.

My Legacy Advisors first reported a position in PFE in Q1 2022 and has held it in 14 quarters since. The position peaked at $969K in Q2 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • My Legacy Advisors held 25,278 shares of Pfizer worth $652K as of Q2 2025.
  • My Legacy Advisors bought 12,951 Pfizer shares in Q2 2025, an estimated $302K.
  • Pfizer made up 0.23% of My Legacy Advisors's portfolio in Q2 2025, its #117 holding.
  • My Legacy Advisors first reported a position in Pfizer in Q1 2022 and has held it in 14 quarters since.
  • My Legacy Advisors's Pfizer position peaked at $969K in Q2 2022.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.